Member Info for The.Italian

Ok the link hasn't worked.im not a member. it says chief scientific officer for regent and plethora from 2016 and gives time as 8yrs i month.

His linked in profile suggests he is still involved.obviously this is not reliable as he could have failed to update it,but 8 years and one month from 2016 would make it current.https://hk.linkedin.com/in/mike-wyllie-0057b411

Very much doubt it,bothwell. china is being run by wanbang bio, so doubt wylie would have had any influence even if he was still involved with regent. aimo

Thanks for that,lse99. much appreciated.

Thanks for that jambor.not sure as to what it means, but at least you've had a response. hopefully clarification will be provided in due course.

Thanks for that,lse99. im afraid I've looked for that statement, but without success. any chance you could point out to me where it is, as that would be greatly appreciated.

Cont.. as to dli, again i have been very concerned by the apparent lack of activity, so the statements today are mildly reassuring. they may be complete blather of course, but i note the reference to "some public hospitals" plural (although the first reference is to hospital singular). if they have indeed started to gain some traction in the hospital sector this would be welcome news and perhaps a prelude to some takeup by the insurance and actuarial sectors.revenue from dli is so far minimal, but i am encouraged by the reference to new products,so again perhaps all is not lost here.

so that's the positive aspect of my response.on the negative side there has been virtually no income from any source.exponential growth of sales in EU seems unlikely based on past experience,but who knows.this leads to the fundamental problem now, which,as you say bignose, is that we are once again running on fumes. finance is needed urgently. will mellon provide some form of loan (convertible loan notes perhaps) or will they go for an equity raise.if i had to guess ,id go for some form of loan,as i doubt there would be any appetite for an equity raise outside of mellon and co (remember the virtual lack of any non mellon take up for the rights issue) this assumes mellon is prepared to stump up a bit more cash rather than write the whole thing off,which i expect is quite likely if we are on the cusp of getting china on to the next stage etc. expect news on this front in next month or so,imo.

Had a couple of re-reads and i have to say my principal reaction is one of relief. i had been seriously concerned that the months of radio silence were indicative of not just delay,but rather of the occurrence of some fundamental and insurmountable problems,which would put an end to both china and us objectives. so, at least so far as china is concerned, i was relieved to see that things are still on track, albeit with an unwelcome delay on the manufacturer and supply front. if they do indeed complete the agreement in that respect and the submission by the end of this quarter (not a lot of time there) then it will be a positive and very welcome step forward.

the fda position is still very unclear, but at least they are not saying that the process has run its course and is now dead in the water, so some relief there also.

as to the suggestion that a manufacturing and supply agreement is unlikely ever to be completed for china, the words "as the agreement has now been finalised" do appear, even to someone of my limited intellect, to be fairly unambiguous. i accept that regent's history does lead one to be cynical, or at least cautious,as to the accuracy of formal statements,but for the time being i am prepared to go on its face value until proven otherwise.

i note the reference to SPA request in november. whilst not absolutely clear, i take this to mean that a request was made in november and that the resulting questions are now being addressed. the outcome, i accept,remains uncertain, but still a slight hope there. tbc

Yes,the bakeaway tie in seems to be yet another very encouraging development.good news.

They did indeed state in the RNS of 12th jan that the intention was to announce the results in march(including strategy), so was also expecting one by today. wont be too bothered though if they overrun a bit, as the substance is going to be more important than the timing. im also interested in what implications the works's proposed move to aim may have(if any).

Well that is the question dandaman. there does seem a very different feel now under the new ceo.i thought the RNS was well written and professional, although the omission of any reference to the ricketts claim does seem a little questionable, particularly as it was deemed to necessitate an RNS on receipt. the claim is a complete unknown at the moment (unless anyone has any more detail) and i doubt ricketts will be holding back on anything he thinks he can get.of course the claim may prove to have little or no substance or easily rebutted,but atm it is a big unknown imo. i have retained my investment here,although it is now pretty much worthless, and will be monitoring developments to see if they start to suggest an opportunity to average down, but will need to see something fairly positive and of substance before doing so.

Morning all. glad they have arrived.had a cursory read as a bit tied up today. will mull things over and re- read later on.

Agreed.seems things are progressing according to plan.

Very strange bignose.i do recall one occasion when an announcement was due,but it didn't actually come out until just before or just after midnight on the relevant day, but obviously nothing is coming out now until the market opens. it's about 5 20 am in hk,i think. not exactly encouraging is it.

Morning bignose. agreed. we'll know tomorrow (i hope) whether there have been any developments.not holding my breath though.

1.1 million usd! freudian slip perhaps.

My summary.we have sold an historic holding which was basically regarded as worthless, for 1.1 USD. this is a huge loss over its acquisition cost (no surprise there). so good news that we will get a payment,but of course it will go absolutely nowhere in th eoverall scheme of things. may help to keep the auditors happy for a couple of months (although it is of course an after the period event for purpose of the forthcoming results. so not really of any significance imo.

4 days until results.will there have been any progress? radio silence suggests not, but who knows!

Johnson looks like a real heavyweight.not quite sure what medda will add, but perhaps she will bring an additional perspective/dimension to the existing mix.

I do wonder if kelso is behind the change, as part of its plan to increase shareholder value. yesterday's RNS refers specifically to kelso as having given an irrevocable undertaking to vote in favour. just speculating of course.